August 01, 2025 03:53 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Former JDS MP Prajwal Revanna convicted in rape case | Election Commission announces date for Vice-Presidential elections | 'Don't be touchy, let's close this': Supreme Court on defamation case against Tharoor over 'scorpion' remark about Modi | Trump ended conflicts including India-Pak, should be awarded Nobel Peace Prize: White House | Donald Trump reveals revised tariff rates: India stands at 25 percent, Pakistan's rates slashed | British Sikh man stabbed to death in London, 5 arrested | Former BJP MP Pragya Thakur, Col Purohit, all other accused acquitted in Malegaon blast case | Congress' sinister conspiracy collapsed, Hindus can never be terrorists: BJP on Malegaon blast verdict | Bangladeshi actress-model Shanta Paul in possession with Indian documents arrested in Kolkata | Rift in INDIA bloc as Priyanka Chaturvedi slams Trump's 'Indian economy is dead' remark contradicting with Rahul
Covid Vaccine
Image Credit: Pixabay

Pfizer- BioNTech seek permission for emergency use of Covid-19 vaccine in adolescents in US

| @indiablooms | Apr 10, 2021, at 06:11 am

Washington/IBNS: US drug major Pfizer Inc and its German partner BioNTech SE have sought the permission for emergency use of their vaccine in adolescents aged 12 to 15, according to a Reuters report.

Pfizer Inc and BioNTech stated that they have made a request to the US Food and Drug Administration for the expansion of use of their vaccine which proved to be 90 per cent effective against the novel coronavirus in clinical trials.

In March, the drugmakers said that their vaccine has shown positive results and proven safe among the age group 12 to 15 in a clinical trial.

This could be a big development as drugmakers across the world are still facing the question if the vaccine works and is safe for use in children.

Inoculating children is a major step toward achieving "herd immunity" and controlling the pandemic, according to experts, the report said.

The companies plan to approach other regulatory authorities across the globe for similar permissions.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu